Coronary Artery Disease or CAD is one of the leading health challenges worldwide. This condition is estimated to impact billions globally and remains a significant burden on healthcare systems.
At Evergrowth, we see this condition as something that will prevail in the upcoming years especially with the current trend in lifestyle. Poor diet, lack of exercise, smoking, and stress, these all contribute to the buildup of plaque in the arteries, narrowing them and impeding blood flow.
Fortunately, with groundbreaking advances in diagnosis and treatment, we’re seeing a revolution in how we tackle CAD. Just like other innovators and investors, Evergrowth is interested in our future with AI-powered diagnostics to precision medicine tailored to your genetic profile.